Transaction · 0001674236-25-000002

CAREY STEPHEN P.

CAREY STEPHEN P., SVP, CFO, reported a transaction classified as grant at ANI PHARMACEUTICALS INC involving 16538.000000 shares for an estimated $0.00. Reported holdings after the transaction were 195814.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ASVP, CFO
ANIPANI PHARMACEUTICALS INC
Filing timeFeb 19
Trade dateFeb 12, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
Returns since

ANIP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANIP since 2025-02-19Filed 562 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001674236-25-000002
Common Stock
Transaction date
Feb 12, 2025
Filed Feb 19, 2025, 01:11 AM · 7d delay
Shares
16.5k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
195k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 7 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership
-22score
Filing-only score

-22

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP & CFO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.

  2. F2

    These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award…

  3. F3

    Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported.

Original filing · 0001674236-25-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANIP